Last 12 months
Inside the activity.
12 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 0 |
| Dec 2025 | 2 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 2 | 0 |
| Sep 2026 | 5 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 22, 2017 Filed Jun 22, 2017 11:49 UTC |
CAUWENBERGH GEERTDirector · President & CEO
|
PurchaseCommon stock, $0.0001 par value | 5,000 | $0.62 | $3,100.00 |
DisclosureSEC source: 0001209191-17-041289 · doc4.xml · nonDerivative · entry 2 CAUWENBERGH GEERT · CIK 0001285648 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,583 Read SEC document |
| June 22, 2017 Filed Jun 22, 2017 11:49 UTC |
CAUWENBERGH GEERTDirector · President & CEO
|
PurchaseCommon stock, $0.0001 par value | 5,000 | $0.63 | $3,150.00 |
DisclosureSEC source: 0001209191-17-041289 · doc4.xml · nonDerivative · entry 1 CAUWENBERGH GEERT · CIK 0001285648 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,583 Read SEC document |
| June 09, 2017 Filed Jun 9, 2017 21:55 UTC |
Eliseev AlexeyChief Business Officer
|
ConversionSeries C Convertible Preferred Stock, $0.0001 par value · Derivative | 332,499 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-039027 · doc4.xml · derivative · entry 2 Eliseev Alexey · CIK 0001694380 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 332,499 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series C Convertible Preferred Stock automatically converted into common stock upon approval by the Company's stockholders in accordance with the stockholder approval requirements of Nasdaq Marketplace Rule 5635 without payment of consideration. The Series C Convertible Preferred Stock have no expiration. F1 · derivative.exercise_date: The Series C Convertible Preferred Stock automatically converted into common stock upon approval by the Company's stockholders in accordance with the stockholder approval requirements of Nasdaq Marketplace Rule 5635 without payment of consideration. The Series C Convertible Preferred Stock have no expiration. F1 · derivative.expiration_date: The Series C Convertible Preferred Stock automatically converted into common stock upon approval by the Company's stockholders in accordance with the stockholder approval requirements of Nasdaq Marketplace Rule 5635 without payment of consideration. The Series C Convertible Preferred Stock have no expiration. Read SEC document |
| June 09, 2017 Filed Jun 9, 2017 21:55 UTC |
Eliseev AlexeyChief Business Officer
|
ConversionCommon stock, $0.0001 par value | 332,499 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-039027 · doc4.xml · nonDerivative · entry 1 Eliseev Alexey · CIK 0001694380 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,150,312 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series C Convertible Preferred Stock automatically converted into common stock upon approval by the Company's stockholders in accordance with the stockholder approval requirements of Nasdaq Marketplace Rule 5635 without payment of consideration. The Series C Convertible Preferred Stock have no expiration. Read SEC document |
| June 06, 2017 Filed Jun 8, 2017 01:13 UTC |
Freeman Jonathan EDirector
|
GrantStock option (right to buy) · Derivative | 3,500 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0001209191-17-038449 · doc4.xml · derivative · entry 1 Freeman Jonathan E · CIK 0001708133 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Underlying: Common stock · 3,500 shares Expires 2027-06-06 F1 · derivative.exercise_date: The stock option vests in equal quarterly installments over one year beginning on the first quarterly anniversary of the grant date. Read SEC document |
| April 26, 2017 Filed Apr 26, 2017 10:52 UTC |
CAUWENBERGH GEERTDirector · President & CEO
|
PurchaseCommon stock, $0.0001 par value | 10,000 | $0.65 | $6,480.00 |
DisclosureSEC source: 0001209191-17-028187 · doc4.xml · nonDerivative · entry 1 CAUWENBERGH GEERT · CIK 0001285648 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,583 Read SEC document |
| April 24, 2017 Filed Apr 26, 2017 22:36 UTC |
Dispersyn GerritChief Development Officer
|
GrantStock option (right to buy) · Derivative | 95,000 | $0.00 Strike: $0.65 | $0.00 |
DisclosureSEC source: 0001209191-17-028260 · doc4.xml · derivative · entry 1 Dispersyn Gerrit · CIK 0001704417 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,000 Underlying: Common stock · 95,000 shares Expires 2027-04-24 F1 · derivative.exercise_date: The stock option vests in equal monthly installments over four years beginning on the first monthly anniversary of the grant date. Read SEC document |
| March 17, 2017 Filed Mar 20, 2017 09:16 UTC |
CAUWENBERGH GEERTDirector · President & CEO
|
PurchaseCommon stock, $0.0001 par value | 15 | $0.77 | $11.48 |
DisclosureSEC source: 0001209191-17-021599 · doc4.xml · nonDerivative · entry 3 CAUWENBERGH GEERT · CIK 0001285648 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,583 Read SEC document |
| March 17, 2017 Filed Mar 20, 2017 09:16 UTC |
CAUWENBERGH GEERTDirector · President & CEO
|
PurchaseCommon stock, $0.0001 par value | 665 | $0.77 | $508.79 |
DisclosureSEC source: 0001209191-17-021599 · doc4.xml · nonDerivative · entry 2 CAUWENBERGH GEERT · CIK 0001285648 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,568 Read SEC document |
| March 17, 2017 Filed Mar 20, 2017 09:16 UTC |
CAUWENBERGH GEERTDirector · President & CEO
|
PurchaseCommon stock, $0.0001 par value | 9,320 | $0.77 | $7,171.74 |
DisclosureSEC source: 0001209191-17-021599 · doc4.xml · nonDerivative · entry 1 CAUWENBERGH GEERT · CIK 0001285648 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,903 Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 07:11 UTC |
CAUWENBERGH GEERTDirector · President & CEO
|
PurchaseCommon stock, $0.0001 par value | 2,917 | $0.70 | $2,027.32 |
DisclosureSEC source: 0001209191-17-012427 · doc4.xml · nonDerivative · entry 3 CAUWENBERGH GEERT · CIK 0001285648 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,583 Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 07:11 UTC |
CAUWENBERGH GEERTDirector · President & CEO
|
PurchaseCommon stock, $0.0001 par value | 6,883 | $0.69 | $4,765.79 |
DisclosureSEC source: 0001209191-17-012427 · doc4.xml · nonDerivative · entry 2 CAUWENBERGH GEERT · CIK 0001285648 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,666 Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 07:11 UTC |
CAUWENBERGH GEERTDirector · President & CEO
|
PurchaseCommon stock, $0.0001 par value | 200 | $0.69 | $138.30 |
DisclosureSEC source: 0001209191-17-012427 · doc4.xml · nonDerivative · entry 1 CAUWENBERGH GEERT · CIK 0001285648 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,783 Read SEC document |
| February 08, 2017 Filed Feb 8, 2017 11:43 UTC |
CAUWENBERGH GEERTDirector · President & CEO
|
PurchaseCommon stock, $0.0001 par value | 10,000 | $0.69 | $6,850.00 |
DisclosureSEC source: 0001209191-17-008542 · doc4.xml · nonDerivative · entry 1 CAUWENBERGH GEERT · CIK 0001285648 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,583 Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 17:17 UTC |
Pavco PamelaChief Development Officer
|
GrantStock option (right to buy) · Derivative | 7,000 | $0.00 Strike: $0.63 | $0.00 |
DisclosureSEC source: 0001209191-17-007724 · doc4.xml · derivative · entry 1 Pavco Pamela · CIK 0001426651 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 7,000 shares Expires 2027-02-01 F1 · derivative.exercise_date: The stock option vests in equal monthly installments over four years beginning on the first monthly anniversary of the grant date. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 17:14 UTC |
CAUWENBERGH GEERTDirector · President & CEO
|
GrantStock option (right to buy) · Derivative | 13,000 | $0.00 Strike: $0.63 | $0.00 |
DisclosureSEC source: 0001209191-17-007720 · doc4.xml · derivative · entry 1 CAUWENBERGH GEERT · CIK 0001285648 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,000 Underlying: Common Stock · 13,000 shares Expires 2027-02-01 F1 · derivative.exercise_date: The stock option vests in a one-quarter installment on the one year anniversary of the grant date and in monthly installments thereafter over the remaining three years. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 22:20 UTC |
Bitterman Robert JDirector
|
GrantStock option (right to buy) · Derivative | 2,000 | $0.00 Strike: $0.63 | $0.00 |
DisclosureSEC source: 0001209191-17-007732 · doc4.xml · derivative · entry 1 Bitterman Robert J · CIK 0001304395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2027-02-01 F1 · derivative.exercise_date: The stock option vests in equal quarterly installments over one year beginning on the first quarterly anniversary of the grant date. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 17:24 UTC |
Lockshin CurtisDirector
|
GrantStock option (right to buy) · Derivative | 2,000 | $0.00 Strike: $0.63 | $0.00 |
DisclosureSEC source: 0001209191-17-007746 · doc4.xml · derivative · entry 1 Lockshin Curtis · CIK 0001383556 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2027-02-01 F1 · derivative.exercise_date: The stock option vests in equal quarterly installments over one year beginning on the first quarterly anniversary of the grant date. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 22:21 UTC |
Brownlie Keith LDirector
|
GrantStock option (right to buy) · Derivative | 2,000 | $0.00 Strike: $0.63 | $0.00 |
DisclosureSEC source: 0001209191-17-007738 · doc4.xml · derivative · entry 1 Brownlie Keith L · CIK 0001518575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2027-02-01 F1 · derivative.exercise_date: The stock option vests in equal quarterly installments over one year beginning on the first quarterly anniversary of the grant date. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 22:22 UTC |
Dorman H. PaulDirector
|
GrantStock option (right to buy) · Derivative | 2,000 | $0.00 Strike: $0.63 | $0.00 |
DisclosureSEC source: 0001209191-17-007742 · doc4.xml · derivative · entry 1 Dorman H. Paul · CIK 0001575028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2027-02-01 F1 · derivative.exercise_date: The stock option vests in equal quarterly installments over one year beginning on the first quarterly anniversary of the grant date. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 22:16 UTC |
Kontulis CaitlinSecretary & Dir. of Finance
|
GrantStock option (right to buy) · Derivative | 2,500 | $0.00 Strike: $0.63 | $0.00 |
DisclosureSEC source: 0001209191-17-007722 · doc4.xml · derivative · entry 1 Kontulis Caitlin · CIK 0001570511 · Secretary & Dir. of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2027-02-01 F1 · derivative.exercise_date: The stock option vests 12.5% on the six month anniversary of the grant date, 12.5% on the one year anniversary of the grant date, and 25% on each of the second, third, and fourth anniversaries of the grant date thereafter. Read SEC document |
| January 25, 2017 Filed Jan 26, 2017 08:05 UTC |
CAUWENBERGH GEERTDirector · President & CEO
|
PurchaseCommon stock, $0.0001 par value | 9,700 | $0.70 | $6,758.96 |
DisclosureSEC source: 0001209191-17-005642 · doc4.xml · nonDerivative · entry 2 CAUWENBERGH GEERT · CIK 0001285648 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,583 Read SEC document |
| January 25, 2017 Filed Jan 26, 2017 08:05 UTC |
CAUWENBERGH GEERTDirector · President & CEO
|
PurchaseCommon stock, $0.0001 par value | 300 | $0.69 | $207.00 |
DisclosureSEC source: 0001209191-17-005642 · doc4.xml · nonDerivative · entry 1 CAUWENBERGH GEERT · CIK 0001285648 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,883 Read SEC document |
| January 19, 2017 Filed Jan 19, 2017 13:48 UTC |
CAUWENBERGH GEERTDirector · President & CEO
|
PurchaseCommon stock, $0.0001 par value | 600 | $0.69 | $416.94 |
DisclosureSEC source: 0001209191-17-004383 · doc4.xml · nonDerivative · entry 3 CAUWENBERGH GEERT · CIK 0001285648 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,583 Read SEC document |
| January 19, 2017 Filed Jan 19, 2017 13:48 UTC |
CAUWENBERGH GEERTDirector · President & CEO
|
PurchaseCommon stock, $0.0001 par value | 3,000 | $0.69 | $2,083.80 |
DisclosureSEC source: 0001209191-17-004383 · doc4.xml · nonDerivative · entry 2 CAUWENBERGH GEERT · CIK 0001285648 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,983 Read SEC document |
| January 19, 2017 Filed Jan 19, 2017 13:48 UTC |
CAUWENBERGH GEERTDirector · President & CEO
|
PurchaseCommon stock, $0.0001 par value | 6,400 | $0.70 | $4,448.00 |
DisclosureSEC source: 0001209191-17-004383 · doc4.xml · nonDerivative · entry 1 CAUWENBERGH GEERT · CIK 0001285648 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,983 Read SEC document |
| December 30, 2016 Filed Jan 3, 2017 06:39 UTC |
CAUWENBERGH GEERTDirector · President & CEO
|
GrantCommon stock, $0.0001 par value | 2,000 | $0.73 | $1,452.00 |
DisclosureSEC source: 0001209191-17-000003 · doc4.xml · nonDerivative · entry 1 CAUWENBERGH GEERT · CIK 0001285648 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,583 Read SEC document |
| December 23, 2016 Filed Dec 27, 2016 06:43 UTC |
CAUWENBERGH GEERTDirector · President & CEO
|
GrantCommon stock, $0.0001 par value | 3,000 | $0.72 | $2,157.00 |
DisclosureSEC source: 0001209191-16-156732 · doc4.xml · nonDerivative · entry 1 CAUWENBERGH GEERT · CIK 0001285648 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 4,500 Read SEC document |
| December 22, 2016 Filed Dec 23, 2016 06:12 UTC |
CAUWENBERGH GEERTDirector · President & CEO
|
GrantCommon stock, $0.0001 par value | 3,000 | $0.75 | $2,247.00 |
DisclosureSEC source: 0001209191-16-156612 · doc4.xml · nonDerivative · entry 1 CAUWENBERGH GEERT · CIK 0001285648 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,583 Read SEC document |
| December 16, 2016 Filed Dec 20, 2016 21:25 UTC |
Pavco PamelaChief Development Officer
|
GrantCommon stock warrant · Derivative | 11,111 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001209191-16-156235 · doc4.xml · derivative · entry 2 Pavco Pamela · CIK 0001426651 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,111 Underlying: Common stock · 11,111 shares Expires 2021-12-21 Read SEC document |
| December 16, 2016 Filed Dec 20, 2016 21:25 UTC |
Pavco PamelaChief Development Officer
|
GrantCommon stock, $0.0001 par value | 11,111 | $0.90 | $9,999.90 |
DisclosureSEC source: 0001209191-16-156235 · doc4.xml · nonDerivative · entry 1 Pavco Pamela · CIK 0001426651 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,173 Read SEC document |
| December 16, 2016 Filed Dec 20, 2016 21:33 UTC |
CAUWENBERGH GEERTDirector · President & CEO
|
GrantCommon stock warrant · Derivative | 33,333 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001209191-16-156238 · doc4.xml · derivative · entry 4 CAUWENBERGH GEERT · CIK 0001285648 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,333 Underlying: Common stock · 33,333 shares Expires 2021-12-21 Read SEC document |
| December 16, 2016 Filed Dec 20, 2016 21:33 UTC |
CAUWENBERGH GEERTDirector · President & CEO
|
GrantCommon stock, $0.0001 par value | 33,333 | $0.90 | $29,999.70 |
DisclosureSEC source: 0001209191-16-156238 · doc4.xml · nonDerivative · entry 1 CAUWENBERGH GEERT · CIK 0001285648 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,583 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.